Depositions in Mesothelioma Lawsuits: Guide to Being Prepared
mesowatch
divider
Gregory Sandifer

Reading Time: 5 mins

Published On: August 30, 2024

Page Features:5 cited research

Gregory Sandifer - contributor

Gregory Sandifer, a trial attorney at The Gori Law Firm, leverages his extensive courtroom experience to prepare mesothelioma cases for trial, focusing on the critical deposition process. His dedication to working closely with victims and their families drives his pursuit of justice.

Jump to a topic


Related Pages

divider

warning icon

Find out if you Qualify for a Asbestos Cancer Lawsuit

warning icon

Find out if you Qualify for a Asbestos Cancer Lawsuit

Depositions in Mesothelioma Lawsuits

Depositions in Mesothelioma Lawsuits

Related Pages

divider
Gregory Sandifer

Reading Time: 5 mins

Published On: August 30, 2024

Page Features:5 cited research

Gregory Sandifer - contributor

Gregory Sandifer, a trial attorney at The Gori Law Firm, leverages his extensive courtroom experience to prepare mesothelioma cases for trial, focusing on the critical deposition process. His dedication to working closely with victims and their families drives his pursuit of justice.

Jump to a topic


5 References

divider

VIEW 0 MORE REFERENCES

Related Content

divider
Is J&J Playing Fair? Lawyers Dispute the $1.1 Billion Talc Settlement Increase
Is J&J Playing Fair? Lawyers Dispute the $1.1 Billion Talc Settlement Increase

Matthew Davis
3 mins read - September 14, 2024

On September 4, Johnson & Johnson boldly announced a $1.1 billion increase to its proposed talc settlement, This would increase the settlement to more than $9 billion paid...

Settlements

J&J Raises Talcum Powder Settlement by Another $1.1 Billion
J&J Raises Talcum Powder Settlement by Another $1.1 Billion

Matthew Davis
3 mins read - September 10, 2024

Johnson & Johnson is planning to pay an additional $1.1 billion in its proposed settlement to clear up tens of thousands of lawsuits alleging the company, and its baby powder...

Featured

FDA Clears Insilico Medicine’s AI-Discovered Drug for Mesothelioma
FDA Clears Insilico Medicine’s AI-Discovered Drug for Mesothelioma

Amna Anees
5 mins read - August 28, 2024

In a groundbreaking development, the U.S. Food and Drug Administration (FDA) has granted Investigational New Drug (IND) clearance to Insilico Medicine’s ISM6331, a potential...

Research

Copyright © 2024 by Mesowatch. All Rights Reserved.
The information on this website is proprietary and protected by law. It is not, nor should it be taken as medical or legal advice. None of the content on this site is intended to substitute for professional medical advice, diagnosis, treatment, or legal counsel. Any unauthorized use, copying, or dissemination will be prosecuted to the fullest extent of the law. Please read our disclaimer for more details.DMCA.com Protection Status